Cell Surface Engineering by Phase‐Separated Coacervates for Antibody Display and Targeted Cancer Cell Therapy
Angewandte Chemie International Edition · 24.10.2024 · 63 (44)
DOI: 10.1002/anie.202410566 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 25.09.2024. Verfasst von Hongfei Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Center for Cell & Developmental Biology, The Chinese University of Hong Kong, Shatin, 99999, Hong Kong SAR, China. Hauptthemen laut MEDLINE: Killer Cells, Natural. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: University Grants Committee, Research Impact Fund, CUHK (ICSG, CRIMS, and Direct Grant).
Abstract (Originalsprache)
Cell therapies such as CAR−T have demonstrated significant clinical successes, driving the investigation of immune cell surface engineering using natural and synthetic materials to enhance their therapeutic performance. However, many of these materials do not fully replicate the dynamic nature of the extracellular matrix (ECM). This study presents a cell surface engineering strategy that utilizes phase‐separated peptide coacervates to decorate the surface of immune cells. We meticulously designed a tripeptide, Fmoc−Lys−Gly−Dopa−OH (KGdelta; Fmoc=fluorenylmethyloxycarbonyl; delta=Dopa, dihydroxyphenylalanine), that forms coacervates in aqueous solution via phase separation. These coacervates, mirroring the phase separation properties of ECM proteins, coat the natural killer (NK) cell surface with the assistance of Fe 3+ ions and create an outer layer capable of encapsulating monoclonal antibodies (mAb), such as Trastuzumab. The antibody‐embedded coacervate layer equips the NK cells with the ability to recognize cancer cells and eliminate them through enhanced antibody‐dependent cellular cytotoxicity (ADCC). This work thus presents a unique strategy of cell surface functionalization and demonstrates its use in displaying cancer‐targeting mAb for cancer therapies, highlighting its potential application in the field of cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Center for Cell & Developmental Biology, The Chinese University of Hong Kong, Shatin, 99999, Hong Kong SAR, China.
- Department of Physics, Hong Kong Baptist University, Kowloon Tong, 99999, Hong Kong SAR, China.
- School of Biomedical Sciences, The University of Hong Kong, Hong Kong, 99999, Hong Kong SAR, China.
ORCID-Profile: Jiang Xia
Förderung
- University Grants Committee
- Research Impact Fund
- CUHK (ICSG, CRIMS, and Direct Grant)
- National Natural Science Foundation of China
Zitieren
APA
Chen, H., Bao, Y., Li, X., Chen, F., Sugimura, R., Zeng, X., & Xia, J. (2024). Cell Surface Engineering by Phase‐Separated Coacervates for Antibody Display and Targeted Cancer Cell Therapy. Angewandte Chemie International Edition, 63(44). https://doi.org/10.1002/anie.202410566
Vancouver
Chen H, Bao Y, Li X, Chen F, Sugimura R, Zeng X, et al. Cell Surface Engineering by Phase‐Separated Coacervates for Antibody Display and Targeted Cancer Cell Therapy. Angewandte Chemie International Edition. 2024;63(44). doi:10.1002/anie.202410566
BibTeX
@article{Chen2024,
author = {Chen, Hongfei and Bao, Yishu and Li, Xiaojing and Chen, Fangke and Sugimura, Ryohichi and Zeng, Xiangze and Xia, Jiang},
title = {Cell Surface Engineering by Phase‐Separated Coacervates for Antibody Display and Targeted Cancer Cell Therapy},
journal = {Angewandte Chemie International Edition},
year = {2024},
volume = {63},
number = {44},
doi = {10.1002/anie.202410566}
}
EUVIMED